| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/26/2002 | US20020137782 Amide substituted benzimidazole or benzoxazole; regulating the interaction of vascular cell adhesion molecule-1 and fibronectin with the integrin vascular cell adhesion molecule very late antigen-4 |
| 09/26/2002 | US20020137745 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease |
| 09/26/2002 | US20020137742 Benzenesulfonamide compounds |
| 09/26/2002 | US20020137716 Administering nucleotide sequence |
| 09/26/2002 | US20020137714 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 09/26/2002 | US20020137687 Novel compounds that inhibit tryptase activity |
| 09/26/2002 | US20020137686 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/26/2002 | US20020137184 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and use thereof |
| 09/26/2002 | US20020137138 Modulating serotonin activity |
| 09/26/2002 | US20020137109 Anticarcinogenic agents;monitoring therapy efficiency |
| 09/26/2002 | US20020137099 Repsiratory system disorders |
| 09/26/2002 | US20020137086 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylation status of the genes |
| 09/26/2002 | US20020136784 Cyclooxygenase-2 (COX-2); administering a plant extract; nonsteroidal anti-inflammatory agents |
| 09/26/2002 | US20020136719 For biomedical applications, including biological delivery to humans and animals |
| 09/26/2002 | US20020134382 Medicament container with same side airflow inlet and outlet and method of use |
| 09/26/2002 | DE10113366A1 Medicament for treating inflammatory or obstructive respiratory diseases, e.g. asthma or chronic obstructive pulmonary disease, containing synergistic combination of anticholinergic agent and endothelin antagonist |
| 09/26/2002 | DE10112771A1 New 3-acylamino-3-phenyl-propionic acid derivatives, are integrin inhibitors useful e.g. for treating thrombosis, cardiac infarction, angina pectoris, tumor diseases, inflammation, osteoporosis or infections |
| 09/26/2002 | CA2469846A1 New interferon beta-like molecules |
| 09/26/2002 | CA2444526A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2442268A1 Benzimidazol derivatives modulate chemokine receptors |
| 09/26/2002 | CA2441291A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/26/2002 | CA2441202A1 Chemical compounds |
| 09/26/2002 | CA2441155A1 Methods of treating respiratory conditions |
| 09/26/2002 | CA2441152A1 Hormone replacement therapy |
| 09/26/2002 | CA2440632A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440631A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440482A1 Tryptase-inhibitors |
| 09/26/2002 | CA2440480A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 09/26/2002 | CA2440475A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
| 09/26/2002 | CA2440264A1 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
| 09/26/2002 | CA2439757A1 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells |
| 09/26/2002 | CA2436911A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors |
| 09/26/2002 | CA2435847A1 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/25/2002 | EP1243589A1 Heteroaryl-substituted pyrrole derivates, their preparation and their therapeutic uses |
| 09/25/2002 | EP1243274A2 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| 09/25/2002 | EP1243271A1 Nasal drops containing fused pyridazine derivatives |
| 09/25/2002 | EP1242608A2 Method of achieving persistent transgene expression |
| 09/25/2002 | EP1242590A2 Human lyases and associated proteins |
| 09/25/2002 | EP1242427A1 Novel piperidine and piperazine derivatives |
| 09/25/2002 | EP1242422A1 Tricyclic dihydropyrimidine potassium channel openers |
| 09/25/2002 | EP1242421A1 4-[aryl(8-azabicyclo[3.2.1] octan-3-yl)] aminobenzoic acid derivatives |
| 09/25/2002 | EP1242415A1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242413A1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels |
| 09/25/2002 | EP1242410A1 Novel compounds |
| 09/25/2002 | EP1242407A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242406A1 Novel compounds |
| 09/25/2002 | EP1242403A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 09/25/2002 | EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242399A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 09/25/2002 | EP1242396A1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 09/25/2002 | EP1242385A1 Cytokine, especially tnf-alpha, inhibitors |
| 09/25/2002 | EP1242382A1 Tricyclic protein kinase inhibitors |
| 09/25/2002 | EP1242381A2 2-phenyl-quinoline derivatives, preparation method and therapeutic use thereof |
| 09/25/2002 | EP1242371A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242364A1 Adamantane derivatives |
| 09/25/2002 | EP1242104A2 Process of obtaining thylakoids from plants, pure thylakoids and use thereof |
| 09/25/2002 | EP1242102A2 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils |
| 09/25/2002 | EP1242073A2 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 09/25/2002 | EP1242068A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 09/25/2002 | EP1242065A1 New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist |
| 09/25/2002 | EP1242048A1 Inhalation particles |
| 09/25/2002 | EP1241935A2 Methods for producing transgenic animals |
| 09/25/2002 | EP1003528B1 Method of enhancing bioavailability of fexofenadine and its derivatives |
| 09/25/2002 | EP0925299B1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 09/25/2002 | EP0923550B1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 09/25/2002 | EP0918540B1 Intradermal bovine polynucleotide vaccine |
| 09/25/2002 | EP0912184B1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 09/25/2002 | EP0910398B1 Method of stimulating cilia |
| 09/25/2002 | EP0702551B1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371359A Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/25/2002 | CN1371285A Methods and compounds for treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 09/25/2002 | CN1371277A Pharmaceutical tramadol salts |
| 09/25/2002 | CN1370596A Mass dissipating and swelling eliminating health beverage |
| 09/25/2002 | CN1370593A Ilicis Folium buccal tablet |
| 09/25/2002 | CN1370578A Medicine liquid for relieving asthma, relieving cough and eliminating phlegm |
| 09/25/2002 | CN1370568A Compound dyspneic cough treating capsule |
| 09/25/2002 | CN1370549A Common cold treating Chinese medicine and its prepn |
| 09/25/2002 | CN1370526A Treating method of nuclear factor-KB mediated diseases and dysfuction |
| 09/25/2002 | CN1370429A Health food |
| 09/24/2002 | US6455572 Estrogen agonist/antagonist metabolites |
| 09/24/2002 | US6455567 Treating dermatological disorders by administering a 3-(pyrrolidin-2-ylmethyl)-5-(aminosulfonylmethyl)indole |
| 09/24/2002 | US6455562 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/24/2002 | US6455561 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase iv or tumour necrosis factor |
| 09/24/2002 | US6455542 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/24/2002 | US6455531 Metalloproteinase inhibitors |
| 09/24/2002 | US6455527 High affinity ligands for nociceptin receptor ORL-1 |
| 09/24/2002 | US6455524 Medicament compositions based on anticholinergically-effective compounds and beta-mimetics |
| 09/24/2002 | US6455520 Benzamide derivatives and their use as cytokine inhibitors |
| 09/24/2002 | US6455517 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455076 Formulations and methods for reducing skin irritation |
| 09/24/2002 | US6455028 Bronchodilator aerosol, propellant |
| 09/24/2002 | CA2261426C Benzimidazole cyclooxygenase-2-inhibitors |
| 09/24/2002 | CA2257807C Improved methods for the synthesis of chemical compounds having pde-iv inhibitory activity |
| 09/23/2002 | CA2341952A1 Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
| 09/20/2002 | WO2001070704A1 Novel imidazole derivatives with anti-inflammatory activity |